Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLeg pain reported alongside Wegovy (semaglutide) is not listed as a common side effect in the medicine's clinical trials, but people do notice it — and the reason usually matters more than the symptom itself. Before assuming the injection is the cause, it's worth working through a short list of more likely explanations, because most turn out to be unrelated to semaglutide. These are prescription-only medicines, and any new or persistent pain in your legs should be discussed with a clinician who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing worth saying clearly: the phase 3 STEP trials, which enrolled thousands of adults over 68 weeks, did not flag leg pain as a common adverse effect of semaglutide 2.4mg. The NHS patient information for semaglutide lists the side effects most frequently reported in trials, and they are dominated by gastrointestinal symptoms such as nausea, diarrhoea and constipation. You can read that list in full on the NHS semaglutide medicines page.
That doesn't mean leg discomfort can't happen while taking Wegovy. It means the medicine itself is rarely the direct mechanism. A common misconception is that any symptom appearing after starting an injection must be caused by it, the timing feels compelling, but correlation isn't causation, and this one is worth letting go of gently before you stop a treatment that may be genuinely helping you.
The more productive question is: what else has changed? Weight, activity levels, hydration and diet all shift during treatment, and those changes carry their own physical effects. Our Wegovy overview covers what the treatment actually does in the body, which can help you separate its known effects from coincidental ones.
Rapid or sustained weight loss changes the mechanical load on your lower limbs in ways that can produce muscle soreness, tendon sensitivity or joint aching, particularly if you have also increased activity during treatment, as most clinical guidance encourages. Legs that are carrying less weight still need time for muscles, tendons and fascia to adjust to the new dynamic.
Reduced caloric intake can sometimes lead to lower potassium, magnesium or sodium levels, particularly if nausea and vomiting have made eating difficult. Electrolyte imbalances are a known cause of muscle cramps and leg aching, and they're easy to miss if you're attributing every symptom to the injection. If you've also experienced significant nausea or vomiting, the stomach pain and Wegovy resource covers how GI symptoms can have downstream effects on how the rest of the body feels.
Reduced physical activity (or a sudden increase in it) can both produce leg pain in their own way. Deconditioning during weeks of appetite suppression, followed by a return to walking or exercise, can make muscles protest in ways that are perfectly normal but poorly timed.
There are patterns of leg pain that need urgent assessment regardless of what medicine you're taking. Sudden, severe pain in one leg (especially paired with swelling, warmth, redness or skin that feels tight) raises the possibility of deep vein thrombosis (DVT). This is not a Wegovy-specific risk, but it is serious. Similarly, pain in the calf that worsens when walking and eases at rest can point to circulatory causes that need a clinician to assess promptly.
If you experience any of those features, call NHS 111 or go to your nearest urgent treatment centre. Don't wait for your next scheduled review. The NHS semaglutide guidance is clear that unexpected or severe symptoms should always be assessed by a healthcare professional without delay. You can also explore some of the related physical discomforts people report on Wegovy (including back pain and injection-site skin reactions) which sometimes get grouped together with leg discomfort but have quite distinct causes.
This is the decision the SK3 framing is built for: should you stop, continue, or seek review? For the vast majority of people experiencing mild, bilateral leg aching that arrived alongside weight loss or increased walking, the answer is to continue and monitor, whilst mentioning it at the next clinical check-in. Stopping a prescription medicine without clinical input is rarely the right move when the symptom has no red-flag features.
For anything that feels unusual, one-sided, severe or that arrived alongside other new symptoms, you need a prescriber involved before making any changes. If you're using Wegovy through a private service like ours, the aftercare team is the right first contact, not a forum, not a general search. Our frequently asked questions cover how aftercare works and what to do if you have a concern between doses.
Semaglutide also slows gastric emptying, which can affect how other oral medicines are absorbed. If you take anything for blood pressure, circulation or muscle conditions alongside Wegovy, it's worth telling your prescriber, especially if leg symptoms appeared after a dose increase. For context on how semaglutide works mechanically, that page goes into more detail on gastric emptying and drug interactions. And if you're thinking about what your ongoing treatment should look like (including cost and what's included) the Wegovy pricing page sets out what a private prescription covers. When you're ready to speak to a prescriber about your symptoms or your next step, you can check your eligibility through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.